Q BioMed Closes $3 Million Equity Funding

Q BIOMED INC. CLOSES $3,050,390 EQUITY FINANCING Funding Provides Capital to Meet Near Term Milestones and Catalysts Q BioMed Inc. (QBIO) is pleased to announce the closing of a $3,050,390 equity financing. The financing with a small group of accredited investors provides the necessary capital to meet near term milestones and catalysts in its most […]

Read More

Q BIOMED INC. ADDS NUCLEAR MEDICINE INDUSTRY VETERAN TO COMMERCIALIZATION TEAM

NEW YORK, June 26 2017 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today that Christopher Manuele will join the Strontium 89 Chloride commercialization team. Mr. Manuele is a results-oriented, innovative executive with thirty-five years of comprehensive US and International expertise in nuclear medicine and medical isotope production. A long-time veteran of […]

Read More

Q BioMed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology for Novel Liver Cancer Treatment

NEW YORK, June 15, 2017 /PRNewswire/ — Q BioMed Inc. (QBIO), is very pleased to announce their entry into a final license agreement with The Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB). Under the agreement QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug […]

Read More

Q BioMed Announces Attendance at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

COMPANY EXECUTIVES AND TECHNOLOGY PARTNERS TO ATTEND INDUSTRY GATHERING JUNE 10-14 2017   NEW YORK, June 9, 2017 — Q BioMed Inc. (OTCQB: QBIO), and executives from its advanced technology partner Bio-Nucleonics Inc. will attend the upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting that is being held in Denver, Colorado June […]

Read More

Q BIOMED INC ANNOUNCES TWO NEW MEMBERS TO ITS SCIENTIFIC ADVISORY BOARD

COMPANY ADDS HIGHLY EXPERIENCED INDUSTRY ADVISORS TO ITS STRATEGIC RESOURCE TEAM   NEW YORK, April 13, 2017 —  Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce the appointment of Dr. Amy Ripka and Dr. Rick Panicucci to its board of scientific advisors.     Dr. Amy Ripka is Executive Director […]

Read More
Social media & sharing icons powered by UltimatelySocial